Cite
HARVARD Citation
Can, M. et al. (n.d.). AB0558 Accelerated infusion rates of RITUXIMAB is well-tolerated and safe in rheumatology practice: A single center experience. Annals of the rheumatic diseases. p. 670. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Can, M. et al. (n.d.). AB0558 Accelerated infusion rates of RITUXIMAB is well-tolerated and safe in rheumatology practice: A single center experience. Annals of the rheumatic diseases. p. 670. [Online].